Seller record · Telehealth service

Trimrose

Fails 2 of 8 criteria. S5, analytical documentation: The program and patient-education pages publish no certificate of analysis or equivalent lot document. 1 more criterion also fails; see the table below.

At a glance

TrimroseTelehealth service

5/8criteria passed
Price
Printed on its own pages before sign-up
Sells
semaglutide injection, tirzepatide injection, oral semaglutide, and 2 more
FDA letters
None on file
Visit TrimroseSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A telehealth platform listing injectable and oral weight-loss medications and longevity prescriptions, with named medical and pharmacy partners and monthly starting prices.

Operating entity Trimrose Inc.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSTrimrose's weight loss category page; Trimrose's longevity category page
S2Prescription gatingPASSTrimrose's weight loss category page
S3Pharmacy identificationPASSTrimrose's longevity category page; Trimrose's weight loss category page
S4Compounding disclosureNOT VERIFIEDTrimrose's weight loss category page; Trimrose's patient education page
S5Analytical documentationFAILTrimrose's weight loss category page; Trimrose's longevity category page; Trimrose's patient education page
S6Business addressFAILTrimrose's about page; Trimrose's privacy policy; Trimrose's terms of service page
S7Price disclosurePASSTrimrose's weight loss category page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe program pages identify the Lion MD medical team and describe licensed providers reviewing individual health assessments before recommending treatment.Source: Trimrose's weight loss category page; Trimrose's longevity category page.
S2PASSThe public program sequence places health assessment and provider review before medication delivery when prescribed.Source: Trimrose's weight loss category page.
S3PASSThe program pages name Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx, Evoluciona Pharma, The Pharmacy Hub and Foothills Pharmacy as pharmacy partners.Source: Trimrose's longevity category page; Trimrose's weight loss category page.
S4NOT VERIFIEDThe compounding-disclosure question did not resolve from the published material. The weight-loss directory includes injectable and oral semaglutide alongside branded drugs but does not clearly identify which preparations are compounded or provide a plain not-FDA-approved disclosure for them. The check is open.Source: Trimrose's weight loss category page; Trimrose's patient education page.
S5FAILThe program and patient-education pages publish no certificate of analysis or equivalent lot document.Source: Trimrose's weight loss category page; Trimrose's longevity category page; Trimrose's patient education page.
S6FAILThe company and legal pages provide email support but no postal address for Trimrose.Source: Trimrose's about page; Trimrose's privacy policy; Trimrose's terms of service page.
S7PASSThe weight-loss directory lists semaglutide injection from $269 a month, tirzepatide injection from $359 a month and oral semaglutide from $299 a month. These are starting prices, not an all-dose guarantee.Source: Trimrose's weight loss category page.
S8PASSNo FDA warning letter names Trimrose or Trimrose Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide injection, tirzepatide injection, oral semaglutide, sermorelin, NAD+.

Visit Trimrose

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.